Detalhe da pesquisa
1.
Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks.
Immunity;
57(2): 287-302.e12, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38354704
2.
Correction of Fanconi Anemia Mutations Using Digital Genome Engineering.
Int J Mol Sci;
23(15)2022 Jul 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35955545
3.
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy.
Mol Ther;
28(1): 52-63, 2020 01 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31704085
4.
Precision Enhancement of CAR-NK Cells through Non-Viral Engineering and Highly Multiplexed Base Editing.
bioRxiv;
2024 Mar 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38496503
5.
Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies.
CRISPR J;
5(4): 517-535, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35972367
6.
MultiEditR: The first tool for the detection and quantification of RNA editing from Sanger sequencing demonstrates comparable fidelity to RNA-seq.
Mol Ther Nucleic Acids;
25: 515-523, 2021 Sep 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34589274
7.
CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells.
Nat Commun;
12(1): 2437, 2021 04 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33893286
8.
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors.
Nat Commun;
10(1): 5222, 2019 11 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31745080
9.
Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors.
Nat Commun;
10(1): 5659, 2019 Dec 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31811147
10.
Highly multiplexed genome engineering using CRISPR/Cas9 gRNA arrays.
PLoS One;
13(9): e0198714, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30222773
11.
EditR: A Method to Quantify Base Editing from Sanger Sequencing.
CRISPR J;
1: 239-250, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31021262